Resources
Advertorials
Interventional radiologists Thomas Albrecht and Roberto Iezzi share their experience performing TACE with degradable starch microspheres (DSM-TACE) using EmboCept S DSM 50 μm
EmboCept® S DSM 50 µm suspension for injection is an adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents, the aim of which is to optimise the intra-tumoral drug accumulation.
EmboCept® is a registered trademark of Magle PharmaCept GmbH.